Linezolid Pharmathen

Linezolid, the active ingredient in Linezolid Pharmathen, is an oxazolidinone presented as an oral tablet for systemic use. It treats infections caused by susceptible Gram‑positive bacteria, including MRSA and VRE, in adult patients.

GNH USA supplies Linezolid Pharmathen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Linezolid is indicated for serious infections caused by Gram‑positive organisms, particularly those resistant to other agents.

- Methicillin‑resistant Staphylococcus aureus (MRSA): effective against skin, soft‑tissue and bloodstream infections. - Vancomycin‑resistant Enterococci (VRE): provides an oral option for resistant enterococcal infections. - Community‑acquired bacterial pneumonia: treats pneumonia caused by susceptible Gram‑positive pathogens. - Skin and soft‑tissue infections: resolves cellulitis and wound infections due to susceptible organisms. - Other Gram‑positive infections: covers a range of infections where the pathogen is susceptible to linezolid.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: transient gastrointestinal upset. - Diarrhea: loose stools, often mild. - Headache: occasional tension‑type headache. - Metallic taste: transient dysgeusia. - Vomiting: occasional emesis. - Fatigue: general tiredness.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count. - Peripheral neuropathy: sensory changes with prolonged use. - Serotonin syndrome: when combined with serotonergic agents. - Lactic acidosis: rare metabolic disturbance. - Optic neuritis: vision changes requiring urgent evaluation. - Myelosuppression: bone‑marrow suppression affecting blood cells.

Before prescribing linezolid, clinicians should assess patient‑specific risk factors and monitor relevant parameters.

- Renal impairment: monitor renal function and adjust therapy as needed. - Hepatic impairment: evaluate liver enzymes regularly. - Concomitant serotonergic drugs: avoid or monitor closely for serotonin syndrome. - Prolonged therapy (>14 days): perform periodic complete blood counts. - Pregnancy: safety unknown; avoid unless benefits outweigh risks. - Store at below 25°C: keep in original packaging, protect from moisture and direct sunlight.

Linezolid interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - Selective serotonin reuptake inhibitors (SSRIs): increased risk of serotonin syndrome. - Monoamine oxidase inhibitors (MAOIs): may precipitate serotonin syndrome. - Rifampicin: markedly reduces linezolid plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, requiring dose adjustment. - Phenytoin: may lower linezolid levels, reducing efficacy. - Theophylline: possible increase in theophylline concentrations, necessitating monitoring.